Tongxinluo promotes mesenchymal stem cell tube formation in vitro

Journal of Zhejiang University: Science B

Volumn 12, Issue 8, 2011, Pages 644-651

  Hu, Xin Yang ^a   Wang, Wen Xia ^a   Yu, Min Jia ^a   Liu B , Xian Bao ^a   Wu, Rong Rong ^a   Gao, Feng ^a   Huang, Xin ^a   Cao, Jiang ^a   Xie, Xiao Jie ^a   Wang, Jian An ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiogenesis; Bone marrow mesenchymal stem cells; Migration; Tongxinluo; Tube formation

Indexed keywords

GELATINASE A; GELATINASE B; HERBACEOUS AGENT; MATRIGEL; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TONGXINLUO; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL SECRETION; CONTROLLED STUDY; DRUG MECHANISM; GELATIN ZYMOGRAPHY; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; RAT; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; LAMININ; MALE; MATRIX METALLOPROTEINASE 2; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

RATTUS;

EID: 80054993370     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1101005     Document Type: Article

References (29)

1. Abdallah, B.M., Kassem, M., 2008. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther., 15(2):109-116. [doi:10.1038/sj.gt.3303067]
2. Baksh, D., Song, L., Tuan, R.S., 2004. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J. Cell. Mol. Med., 8(3): 301-316. [doi:10.1111/j.1582-4934.2004.tb00320.x] (Pubitemid 44145494)
3. Behfar, A., Yamada, S., Crespo-Diaz, R., Nesbitt, J.J., Rowe, L.A., Perez-Terzic, C., Gaussin, V., Homsy, C., Bartunek, J., Terzic, A., 2010. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J. Am. Coll. Cardiol., 56(9):721-734. [doi:10.1016/j.jacc.2010.03.066]
4. Birkedal-Hansen, H., Moore, W.G., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A., Engler, J.A., 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med., 4(2):197-250. (Pubitemid 23103292)
5. Dai, J., Rabie, A.B., 2007. VEGF: an essential mediator of both angiogenesis and endochondral ossification. J. Dent. Res., 86(10):937-950. [doi:10.1177/154405910708601006]
6. Gao, F., He, T., Wang, H., Yu, S., Yi, D., Liu, W., Cai, Z., 2007. A promising strategy for the treatment of ischemic heart disease: mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can. J. Cardiol., 23(11):891-898. [doi:10.1016/S0828-282X(07) 70845-0] (Pubitemid 350011270)
7. Kim, T.S., Kim, Y.B., 1999. Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma. J. Korean Med. Sci., 14:263-270.
8. Lamalice, L., Le Boeuf, F., Huot, J., 2007. Endothelial cell migration during angiogenesis. Circ. Res., 100(6):782-794. [doi:10.1161/01.RES.0000259593. 07661.1e] (Pubitemid 46555683)
9. Li, X.D., Yang, Y.J., Geng, Y.J., Jin, C., Hu, F.H., Zhao, J.L., Zhang, H.T., Cheng, Y.T., Qian, H.Y., Wang, L.L., et al., 2010. Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway. Am. J. Physiol. Heart Circ. Physiol., 299(4):H1255-H1261. [doi:10.1152/ajpheart.00459.2010]
10. Liang, J.Q., Wu, K., Jia, Z.H., Liu, C., Ding, J., Huang, S.N., Yin, P.P., Wu, X.C., Wei, C., Wu, Y.L., et al., 2011. Chinese medicine Tongxinluo modulates vascular endothelial function by inducing eNOS expression via the PI-3K/Akt/HIF-dependent signaling pathway. J. Ethnopharmacol., 133(2):517-523. [doi:10.1016/j.jep.2010.10. 031]
11. Matsumoto, R., Omura, T., Yoshiyama, M., Hayashi, T., Inamoto, S., Koh, K.R., Ohta, K., Izumi, Y., Nakamura, Y., Akioka, K., et al., 2005. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol., 25(6):1168-1173. [doi:10. 1161/01.ATV.0000165696.25680.ce] (Pubitemid 40776604)
12. Nagase, H., Woessner, J.J., 1999. Matrix metalloproteinases. J. Biol. Chem., 274(31):21491-21494. [doi:10.1074/jbc.274. 31.21491] (Pubitemid 29359963)
13. Nguyen, B.K., Maltais, S., Perrault, L.P., Tanguay, J.F., Tardif, J.C., Stevens, L.M., Borie, M., Harel, F., Mansour, S., Noiseux, N., 2010. Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. J. Cardiovasc. Transl. Res., 3(5):547-558. [doi:10.1007/ s12265-010-9171-0]
14. Ohno-Matsui, K., Uetama, T., Yoshida, T., Hayano, M., Itoh, T., Morita, I., Mochizuki, M., 2003. Reduced retinal angiogenesis in MMP-2-deficient mice. Invest. Ophthalmol. Vis. Sci., 44(12):5370-5375. [doi:10.1167/iovs.03-0249] (Pubitemid 37475412)
15. Olsson, A.K., Dimberg, A., Kreuger, J., Claesson-Welsh, L., 2006. VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell Biol., 7(5):359-371. [doi:10. 1038/nrm1911]
16. Orlic, D., Kajstura, J., Chimenti, S., Bodine, D.M., Leri, A., Anversa, P., 2003. Bone marrow stem cells regenerate infarcted myocardium. Pediatr. Transplant., 7(Suppl. 3): 86-88. [doi:10.1034/j.1399-3046.7.s3.13.x] (Pubitemid 36314227)
17. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., Marshak, D.R., 1999. Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411):143-147. [doi:10.1126/science.284.5411.143] (Pubitemid 29282067)
18. Qian, H.Y., Yang, Y.J., Huang, J., Gao, R.L., Dou, K.F., Yang, G.S., Li, J.J., Shen, R., He, Z.X., Lu, M.J., et al., 2007. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts. Chin. Med. J. (Engl.), 120(16):1416-1425. (Pubitemid 47364973)
19. Raffetto, J.D., Khalil, R.A., 2008. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem. Pharmacol., 75(2):346-359. [doi:10. 1016/j.bcp.2007.07.004] (Pubitemid 350298459)
20. Stetler-Stevenson, W.G., 2008. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci. Signal., 1(27):re6. [doi:10.1126/ scisignal.127re6]
21. Tomita, S., Li, R.K., Weisel, R.D., Mickle, D.A.G., Kim, E.J., Sakai, T., Jia, Z.Q., 1999. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation, 100(Suppl. II):247-256. [doi:10.1161/01. CIR.100.suppl-2.II-247]
22. Tse, H.F., Yiu, K.H., Lau, C.P., 2007. Bone marrow stem cell therapy for myocardial angiogenesis. Curr. Vasc. Pharmacol., 5(2):103-112. [doi:10.2174/157016107780368299]
23. Wang, H.J., Huang, Y.W., Sun, J., 2003. Effect of tongxinluo capsule on function of vascular endothelium in patients with unstable angina pectoris. Chin. J. Integr. Trad. West. Med., 23(8):587-589 (in Chinese).
24. Wang, J.A., Chen, T.L., Jiang, J., Shi, H., Gui, C., Luo, R.H., Xie, X.J., Xiang, M.X., Zhang, X., 2008. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol. Sin., 29(1):74-82. [doi:10.1111/j.1745-7254.2008.00716.x]
25. Wu, T., Harrison, R.A., Chen, X., Ni, J., Zhou, L., Qiao, J., Wang, Q., Wei, J., Xin, D., Zheng, J., 2006. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris. Cochrane Database Syst. Rev., (4): CD004474. [doi:10.1002/14651858.CD004474.pub2] (Pubitemid 46850616)
26. Xu, F., Shi, J., Yu, B., Ni, W., Wu, X., Gu, Z., 2010. Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncol. Rep., 23(6):1561-1567. [doi:10.3892/or-00000796]
27. Zhang, H.T., Jia, Z.H., Zhang, J., Ye, Z.K., Yang, W.X., Tian, Y.Q., Jia, X., Li, W., Wu, Y.L., Yang, Y.J., 2010. No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial). Chin. Med. J. (Engl.), 123(20):2858-2864.
28. Zhu, F., Guo, G.H., Chen, W., Wang, N.Y., 2010. Effects of bone marrow-derived mesenchymal stem cells engraftment on vascular endothelial cell growth factor in lung tissue and plasma at early stage of smoke inhalation injury. World J. Emerg. Med., 1:224-228.
29. Zisa, D., Shabbir, A., Suzuki, G., Lee, T., 2009. Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. Biochem. Biophys. Res. Commun., 390(3):834-838. [doi:10.1016/j.bbrc.2009.10. 058]